Acid citrate dextrose (acd) formula a as a new anticoagulant in the measurement of in vitro platelet aggregation
โ Scribed by Pasquale Pignatelli; Fabio M. Pulcinelli; Filippo Ciatti; Marzia Pesciotti; Silvia Sebastiani; Patrizia Ferroni; Pier Paolo Gazzaniga
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 302 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
โฆ Synopsis
To evaluate whether the use of ACD Formula A may affect in vitro platelet function, blood samples were obtained from 21 healthy blood donors and anticoagulated in ACD (acid-citrate dextrose, NIH Formula A), Na citrate 3.8%, and K3EDTA. Platelet count, mean platelet volume, and in vitro platelet aggregation were evaluated on each sample. No significant difference was observed in platelet count and mean platelet volume among the different samples. Conversely, theACD treated platelets showed a higher reactivity to the agonists as demonstrated by a significant increase of the maximum percentages of aggregation induced by ADP, epinephrine, and collagen, as well as a significant decrease of secondary aggregation thresholds to ADP and epinephrine. In conclusion, it may be speculated that ACD Formula A is capable of better maintaining the intraplatelet signal transduction mechanisms during PRP preparation, thus improving the overall responsiveness of platelets.
๐ SIMILAR VOLUMES
## Abstract Ethylenediaminetetraacetic acid (EDTA) is the anticoagulant recommended for full blood counts, citrate is recommended for coagulation and platelet studies, and citrateโtheophyllineโadenosineโdipyridamole (CTAD) inhibits platelet activation. Because the combination of EDTA and CTAD (E/C)
Synthesis of a New Class of Camptothecin Derivatives, the Long-Chain Fatty Acid Esters of 10-Hydroxycamptothecin, as a Potent Prodrug Candidate, and Their in vitro Metabolic Conversion of Carboxylesterases. -The Friedlaender condensation strategy is used for the construction of the quinoline system
ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Part 2. Synthesis and Evaluation of (3R\*,5S\*)-ฯ-Substituted-3carboxy-3,5-dihydroxyalkanoic Acids and Their ฮณ-Lactone Prodrugs as Inhibitors of the Enzyme in vitro and in vivo. -A series of the title compounds is synthesized and evalua